Form4insider filings, from the source

SEC Form 3 · accession 0000899243-19-003480

TCR2 THERAPEUTICS INC. · TCRR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 13, 2019
Accepted (ET)
Feb 13, 2019 · 6:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001750019

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———36,731D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F3,F2$0.74holding————Dec 13, 2026Common Stock8,017—I
Warrants to Purchase Common Stock (Right to Buy)F3,F4$0.74holding————Dec 5, 2027Common Stock25,407—I

Explanation of responses

Remarks

Exhibit 24.1: Power of Attorney